FHIR © HL7.org | Server Home | FHIR Server FHIR Server 3.7.13 | FHIR Version n/a User: [n/a]

409406007: Bevacizumab (substance)

Status: current, Primitive. Date: 31-Jul 2004. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2464857019 Bevacizumab (substance) en Fully specified name Active Case insensitive SNOMED CT core

2471192013 Bevacizumab en Synonym Active Case insensitive SNOMED CT core

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Bevacizumab	Has disposition	Vascular endothelial growth factor receptor antagonist	true	Inferred relationship	Some
Bevacizumab	Is a	Vascular endothelial growth factor receptor antagonist	true	Inferred relationship	Some
Bevacizumab	Is a	Monoclonal antibody agent	false	Inferred relationship	Some
Bevacizumab	Is a	Angiogenesis inhibitor	true	Inferred relationship	Some
Bevacizumab	Is a	Monoclonal antibody	true	Inferred relationship	Some
Bevacizumab	Has disposition	Angiogenesis inhibitor	true	Inferred relationship	Some
Bevacizumab	Is a	Antineoplastic agent	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Bevacizumab only product	Has active ingredient	True	Bevacizumab	Inferred relationship	Some	1
Bevacizumab only product in parenteral dose form	Has active ingredient	True	Bevacizumab	Inferred relationship	Some	1
Bevacizumab 25 mg/mL solution for injection	Has BoSS	True	Bevacizumab	Inferred relationship	Some	1
Bevacizumab 25 mg/mL solution for injection	Has precise active ingredient	True	Bevacizumab	Inferred relationship	Some	1
Bevacizumab-containing product	Has active ingredient	True	Bevacizumab	Inferred relationship	Some	1
Bevacizumab 25mg/mL injection solution 4mL vial	Has active ingredient	False	Bevacizumab	Inferred relationship	Some
Bevacizumab 25mg/mL injection solution 16mL vial	Has active ingredient	False	Bevacizumab	Inferred relationship	Some
Bevacizumab-containing product in parenteral dose form	Has active ingredient	True	Bevacizumab	Inferred relationship	Some	1
Bevacizumab 400 mg/16 mL solution for injection vial	Has BoSS	False	Bevacizumab	Inferred relationship	Some	1
Bevacizumab 400 mg/16 mL solution for injection vial	Has precise active ingredient	False	Bevacizumab	Inferred relationship	Some	1
Bevacizumab 100 mg/4 mL solution for injection vial	Has BoSS	False	Bevacizumab	Inferred relationship	Some	1
Bevacizumab 100 mg/4 mL solution for injection vial	Has precise active ingredient	False	Bevacizumab	Inferred relationship	Some	1

Reference Sets

Adverse reaction agent reference set